SIV attacks memory cells

Credit: PROFESSORS PIETRO M. MOTTA © TOMONORI NAGURO / PHOTO RESEARCHERS" /> Credit: PROFESSORS PIETRO M. MOTTA © TOMONORI NAGURO / PHOTO RESEARCHERS The paper: J.J. Mattapallil et al., "Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection," Nature, 434:1093-7, 2005. (Cited in 98 papers) The finding: Simian immunodeficiency virus (SIV) and HIV are known to reduce CD4+ T cells dramati

Written byCathy Tran
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The paper:

J.J. Mattapallil et al., "Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection," Nature, 434:1093-7, 2005. (Cited in 98 papers)

The finding:

Simian immunodeficiency virus (SIV) and HIV are known to reduce CD4+ T cells dramatically. Research by Mario Roederer at the National Institute of Health and his colleagues showed that this happens during acute infection, suggesting that this is an important time to reduce viral load therapeutically.

The follow-up:

CD4+ T cells in SIV-infected infant macaques have the same rate of depletion, according to in press work by Ronald Veazey at Tulane University. What's surprising, he says, is the substantial amount of CD4+ T cells in uninfected infants, perhaps suggesting that "the immune system is cranked up very early after birth."

The application:

Roederer's team reported in 2006 that vaccination reduces CD4+ T cell depletion during acute SIV infection in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies